SCHEMBL276016

SCHEMBL276016

CCOC(=O)C1CCCCC1=O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 1/20 0.51
CYP2D6 P10635 1/20 0.50
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
KDM4E B2RXH2 2/20 0.49
HSD17B10 Q99714 2/20 0.49
GAA P10253 2/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.46
MCL1 Q07820 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470785 1.00 TLR4 (0.51) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL929873 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL28368812 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL10792572 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL3656801 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL7733726 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL7392059 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL7697030 0.98 TLR4 (0.50) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL321283 0.95 TLR4 (0.52) TLR4CYP2D6ALDH1A1MAPTKMT2A
SCHEMBL12606807 0.95 TLR4 (0.52) TLR4CYP2D6ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2045 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747238-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS Sanofi (FR) 2026-05-27 EP claimed
CN-121586706-A Process for the preparation of intermediates for sartan active compounds 赛诺菲 2026-02-27 CN claimed
WO-2025021696-A1 PROCESS FOR PREPARING INTERMEDIATES OF SARTAN ACTIVE COMPOUNDS SANOFI (FR) 2025-01-30 WO claimed
US-20240400792-A1 CURABLE (METH)ACRYLATE COMPOSITIONS HENKEL AG & CO KGAA (DE) 2024-12-05 US claimed
CN-118355086-A Curable (meth) acrylate composition 汉高股份有限及两合公司 2024-07-16 CN claimed
WO-2023229323-A1 METHOD FOR PREPARING 6-METHOXYPYRIDIN-3-YL DERIVATIVE 일동제약(주) 2023-11-30 WO claimed
CN-117069585-A Preparation method of ethyl 2-cyclohexanone formate 烟台舜康生物科技有限公司 2023-11-17 CN claimed
WO-2023104819-A1 CURABLE (METH) ACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2023-06-15 WO claimed
CN-113789527-B Electrochemical synthesis method of aromatic amine 四川大学 2023-02-28 CN claimed
EP-4126862-A1 PROCESS FOR PREPARING A COT INHIBITOR COMPOUND GILEAD SCIENCES, INC. (US) 2023-02-08 EP claimed
EP-0912467-B1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE SA (FR) 2002-04-24 EP claimed
CN-1070181-C Organic peroxide stabilization with beta-dicarbonyl or cyclic alpha-diketone compounds CK WITCO CORP (US) 2001-08-29 CN claimed
EP-0912467-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1999-05-06 EP claimed
WO-1998000375-A1 ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE RHODIA CHIMIE (FR) 1998-01-08 WO claimed
US-5149813-A Alleviating memory dysfunctions HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-09-22 US claimed
EP-0134889-B1 CYCLOHEXANE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF AS ANTIDYSRHYTHMIC AGENTS PENNWALT CORPORATION (US) 1987-11-11 EP claimed
EP-0134889-A2 Cyclohexane carboxylic acids and derivatives thereof as antidysrhythmic agents PENNWALT CORPORATION (US) 1985-03-27 EP claimed
US-4460786-A Process for the selective addition of a compound having an activated carbon atom onto a substituted conjugated diene RHONE-POULENC INDUSTRIES (FR) 1984-07-17 US claimed
EP-0044771-B1 PROCESS FOR THE SELECTIVE ADDITION OF A COMPOUND HAVING AN ACTIVATED CARBON ATOM TO A SUBSTITUTED CONJUGATED DIENE RHONE-POULENC SANTE (FR) 1984-05-02 EP claimed
EP-0044771-A1 Process for the selective addition of a compound having an activated carbon atom to a substituted conjugated diene RHONE-POULENC SANTE (FR) 1982-01-27 EP claimed